Holdings of Amplify Weight Loss Drug & Treatment ETF
Amplify ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 4.2M $ including 4M $ in equities, 95.2 %
- Positions
- 20 in 7 countries
- Top ten
- 66.5 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Novo Nordisk A/S | 13,431 | 493.6K $ | 11.89 % |
| 2 | Eli Lilly & Co | 522 | 480.1K $ | 11.56 % |
| 3 | Regeneron Pharmaceuticals, Inc. | 364 | 281.2K $ | 6.77 % |
| 4 | Amgen Inc | 740 | 260.4K $ | 6.27 % |
| 5 | Chugai Pharmaceutical Co Ltd | 4,600 | 249K $ | 6.00 % |
| 6 | CSPC Pharmaceutical Group Ltd | 180,000 | 208.9K $ | 5.03 % |
| 7 | Arrowhead Pharmaceuticals Inc | 3,287 | 206.1K $ | 4.96 % |
| 8 | AbbVie Inc | 907 | 197.3K $ | 4.75 % |
| 9 | AstraZeneca PLC | 980 | 193.3K $ | 4.66 % |
| 10 | Pfizer Inc | 6,828 | 191.7K $ | 4.62 % |
| 11 | Merck & Co Inc | 1,546 | 186K $ | 4.48 % |
| 12 | Shionogi & Co Ltd | 8,500 | 185.3K $ | 4.46 % |
| 13 | Roche Holding AG | 473 | 185.2K $ | 4.46 % |
| 14 | Innovent Biologics Inc | 17,000 | 184.1K $ | 4.43 % |
| 15 | Scholar Rock Holding Corp | 2,005 | 98.6K $ | 2.37 % |
| 16 | Viking Therapeutics Inc | 2,818 | 91.7K $ | 2.21 % |
| 17 | Structure Therapeutics Inc | 1,738 | 83.8K $ | 2.02 % |
| 18 | Zealand Pharma A/S | 1,584 | 72.1K $ | 1.74 % |
| 19 | Hanmi Pharm Co Ltd | 158 | 53.1K $ | 1.28 % |
| 20 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 6,200 | 51K $ | 1.23 % |
Sector breakdown
- Health care 62.5 %
- Unattributed 37.5 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 69.9 %
- HKD 11.2 %
- JPY 11.0 %
- CHF 4.7 %
- DKK 1.8 %
- KRW 1.3 %
The quoted currency of each line, as declared.
Country breakdown
- United States 52.5 %
- Denmark 14.3 %
- Hong Kong SAR China 11.2 %
- Japan 11.0 %
- United Kingdom 4.9 %
- Switzerland 4.7 %
- South Korea 1.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 10 | 2.1M $ | 52.55 % |
| 2 | Denmark | 2 | 565.6K $ | 14.31 % |
| 3 | Hong Kong SAR China | 3 | 444K $ | 11.23 % |
| 4 | Japan | 2 | 434.3K $ | 10.99 % |
| 5 | United Kingdom | 1 | 193.3K $ | 4.89 % |
| 6 | Switzerland | 1 | 185.2K $ | 4.69 % |
| 7 | South Korea | 1 | 53.1K $ | 1.34 % |
Cite this page
Titelia. "Holdings of Amplify Weight Loss Drug & Treatment ETF". https://titelia.com/en/funds/S000085024